Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions
Conditions
Interventions
CKD-387
D484
Locations
1
South Korea
Bumin Hospital
Seoul, South Korea
Start Date
September 19, 2022
Primary Completion Date
September 29, 2022
Completion Date
October 5, 2022
Last Updated
May 3, 2024
Lead Sponsor
Chong Kun Dang Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions